| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-RISPERIDONE | 4.0MG | TABLET | Avoided shortage | 2017-03-17 | 2017-03-29 | 3368 |
| MYLAN-RISPERIDONE | 1.0MG | TABLET | Resolved | 2017-04-04 | 2017-09-08 | 5319 |
| MYLAN-RISPERIDONE | 2.0MG | TABLET | Resolved | 2017-04-04 | 2017-10-04 | 5338 |
| MYLAN-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-05-02 | 2021-11-23 | 8719 |
| MYLAN-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-03-17 | 2021-11-23 | 3346 |
| MYLAN-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-03-10 | 2021-11-23 | 206 |
| MYLAN-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-05-03 | 2021-11-23 | 8764 |
| MYLAN-RISPERIDONE ODT | 0.5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-03-17 | 2021-11-23 | 3360 |
| PMS-RISPERIDONE | 2.0MG | TABLET | Resolved | 2017-09-08 | 2017-11-09 | 21715 |
| PMS-RISPERIDONE | 2.0MG | TABLET | Resolved | 2018-05-04 | 2018-07-13 | 48558 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-RISPERIDONE | 4MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258688 |
| TEVA-RISPERIDONE | 3MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258685 |
| TEVA-RISPERIDONE | 2MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258679 |